Drug
Vctx211
Vctx211: highest development phase Phase 1, developed by CRISPR Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- CRISPR Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| VCTX211 NCT05565248 | Phase 1 | Diabetes Mellitus |
Latest
No recent events.
Follow Vctx211 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.